Eldhose Iype
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Eldhose Iype has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Indresh Kumar
Department of Chemistry, Birla Institute of Technology and Science, Pilani, Pilani Campus, Vidya Vihar, Pilani, Rajasthan 333031, India
8 shared publications Jyothi Yadav
Department of Chemistry, Birla Institute of Technology and Science, Pilani, Pilani Campus, Vidya Vihar, Pilani, Rajasthan 333031, India
7 shared publicationsKrishnan Rangan
Department of Chemistry, BITS Pilani, Hyderabad Campus, Secunderabad, India
4 shared publicationsAmol Prakash Pawar
Department of Chemistry, Birla Institute of Technology and Science, Pilani 333 031, Rajasthan, India
3 shared publicationsAtul Jankiram Dolas
Department of Chemistry, Birla Institute of Technology and Science, Pilani 333031, Rajasthan, India
3 shared publicationsSadhya Gulati
BITS Pilani, Dubai Campus
3 shared publications
Latest Publications
- 24 March 2026
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 24 (15) , 3180-3191
Recent developments in asymmetric synthesis of cyclohepta[ b ]indole derivatives
This review article covers the current state of asymmetric synthetic methods for functionalized cyclohepta[ b ]indoles, which have attracted significant interest due to their presence in many bioactive compounds.
- 24 March 2026
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 24 (15) , 3180-3191
Recent developments in asymmetric synthesis of cyclohepta[ b ]indole derivatives
This review article covers the current state of asymmetric synthetic methods for functionalized cyclohepta[ b ]indoles, which have attracted significant interest due to their presence in many bioactive compounds.
- Open Access
- 26 February 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (13) , 11478-11495
Recent developments in the organocatalytic asymmetric cycloaddition/annulation reactions involving indolylmethanols
Enantioenriched indole frameworks constitute the structural core of a wide array of biologically active natural products and therapeutic agents; as such, their synthesis has emerged as a central and enduring objective in organic synthesis. In this regard, suitably substituted indolylmethanols have emerged as versatile precursors to a series of catalytic asymmetric transformations to construct complex indole-based architectures. This article provides a concise overview of the fundamental chemistry of n-indolylmethanols, with a specific emphasis on their role as key substrates in enantioselective cycloadditions catalyzed by chiral phosphoric acids.
- 26 February 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (13) , 11478-11495
Open AccessRecent developments in the organocatalytic asymmetric cycloaddition/annulation reactions involving indolylmethanols
Enantioenriched indole frameworks constitute the structural core of a wide array of biologically active natural products and therapeutic agents; as such, their synthesis has emerged as a central and enduring objective in organic synthesis. In this regard, suitably substituted indolylmethanols have emerged as versatile precursors to a series of catalytic asymmetric transformations to construct complex indole-based architectures. This article provides a concise overview of the fundamental chemistry of n-indolylmethanols, with a specific emphasis on their role as key substrates in enantioselective cycloadditions catalyzed by chiral phosphoric acids.
- 30 January 2025
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (11) , 2523-2538
Recent developments in the catalytic asymmetric synthesis of indolin-3-one derivatives
2,2-Disubstituted indolin-3-ones, which are essential components in many manufactured chemicals, dyes, and naturally occurring bioactive alkaloids, have emerged as exciting synthetic targets. Much attention has been paid to accessing these units, particularly in an asymmetric fashion, during the last decade. In this review article, we discuss the current state of available methods with existing mechanistic pathways for accessing chiral indolin-3-one derivatives under various catalytic systems. This overall presentation of asymmetric catalytic protocols to access 2,2-disubstituted or fused indolin-3-ones with an aza-quaternary centre is categorized based on the reaction modes of 2-substituted-3H-indole-3-one derivatives or other similar protocols.
- 30 January 2025
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (11) , 2523-2538
Recent developments in the catalytic asymmetric synthesis of indolin-3-one derivatives
2,2-Disubstituted indolin-3-ones, which are essential components in many manufactured chemicals, dyes, and naturally occurring bioactive alkaloids, have emerged as exciting synthetic targets. Much attention has been paid to accessing these units, particularly in an asymmetric fashion, during the last decade. In this review article, we discuss the current state of available methods with existing mechanistic pathways for accessing chiral indolin-3-one derivatives under various catalytic systems. This overall presentation of asymmetric catalytic protocols to access 2,2-disubstituted or fused indolin-3-ones with an aza-quaternary centre is categorized based on the reaction modes of 2-substituted-3H-indole-3-one derivatives or other similar protocols.
- 7 November 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (1) , 98-102
Enantioselective synthesis of α-(3-pyrrolyl)methanamines with an aza-tetrasubstituted center under metal-free conditions
Construction of a chiral methanamine unit at the C3 position of pyrrole is highly desirable; nevertheless, it remains challenging due to its intrinsic electronic properties. Herein, we present an operationally straightforward and direct asymmetric approach for accessing α-(3-pyrrolyl)methanamines under benign organocatalytic conditions for the first time. The one-pot transformation proceeds smoothly through an amine-catalyzed direct Mannich reaction of succinaldehyde with various endo-cyclic imines, followed by a Paal–Knorr cyclization with a primary amine. Several N–H/alkyl/Ar α-(3-pyrrolyl)methanamines with an aza-tetrasubstituted center have been synthesized with good yields and excellent enantioselectivity.
- 7 November 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (1) , 98-102
Enantioselective synthesis of α-(3-pyrrolyl)methanamines with an aza-tetrasubstituted center under metal-free conditions
Construction of a chiral methanamine unit at the C3 position of pyrrole is highly desirable; nevertheless, it remains challenging due to its intrinsic electronic properties. Herein, we present an operationally straightforward and direct asymmetric approach for accessing α-(3-pyrrolyl)methanamines under benign organocatalytic conditions for the first time. The one-pot transformation proceeds smoothly through an amine-catalyzed direct Mannich reaction of succinaldehyde with various endo-cyclic imines, followed by a Paal–Knorr cyclization with a primary amine. Several N–H/alkyl/Ar α-(3-pyrrolyl)methanamines with an aza-tetrasubstituted center have been synthesized with good yields and excellent enantioselectivity.
- 6 July 2023
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 47 (31) , 14637-14645
Two-pot sequential multicomponent metal-free synthesis of pyrrolo[2,3- d ]pyridazin-7-ones and pyrrolo[2,3- d ]pyrizidines
A two-pot process is developed to access pyrrolo[2,3- d ]pyridazin-7-one's and pyrrolo[2,3- d ]pyrizidines through the pyrrole-2,3-dione as an intermediate compound.
- 6 July 2023
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 47 (31) , 14637-14645
Two-pot sequential multicomponent metal-free synthesis of pyrrolo[2,3- d ]pyridazin-7-ones and pyrrolo[2,3- d ]pyrizidines
A two-pot process is developed to access pyrrolo[2,3- d ]pyridazin-7-one's and pyrrolo[2,3- d ]pyrizidines through the pyrrole-2,3-dione as an intermediate compound.
- 23 August 2022
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 20 (35) , 7040-7046
PIFA-promoted intramolecular oxidative cyclization of pyrrolo- and indolo[1,2-a]quinoxalino-appended porphyrins: an efficient synthesis of meso,β-pyrrolo- and indolo[1,2-a]quinoxalino-fused porphyrins
Developed an efficient protocol to prepare meso-β-pyrrolo- and indolo[1,2-a]quinoxalino-fused porphyrins exhibiting red-shifted absorption spectra near NIR region.
- 23 August 2022
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 20 (35) , 7040-7046
PIFA-promoted intramolecular oxidative cyclization of pyrrolo- and indolo[1,2-a]quinoxalino-appended porphyrins: an efficient synthesis of meso,β-pyrrolo- and indolo[1,2-a]quinoxalino-fused porphyrins
Developed an efficient protocol to prepare meso-β-pyrrolo- and indolo[1,2-a]quinoxalino-fused porphyrins exhibiting red-shifted absorption spectra near NIR region.
- 24 June 2022
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 20 (29) , 5747-5758
Catalyst-free direct regiospecific multicomponent synthesis of C3-functionalized pyrroles
A catalyst-free multicomponent method has been developed for the direct regiospecific synthesis of β-(C3)-substituted N -alkyl/aryl/H-pyrroles in good yields under mild conditions with high atom economy and avoiding protection–deprotection chemistry.
- 24 June 2022
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 20 (29) , 5747-5758
Catalyst-free direct regiospecific multicomponent synthesis of C3-functionalized pyrroles
A catalyst-free multicomponent method has been developed for the direct regiospecific synthesis of β-(C3)-substituted N -alkyl/aryl/H-pyrroles in good yields under mild conditions with high atom economy and avoiding protection–deprotection chemistry.
- 1 January 2022
- Published by Springer Nature
- p. 131-138
Kinetic Energy Correction Factor for a Converging–Diverging Nozzle
- 1 January 2022
- Published by Springer Nature
- p. 131-138
Kinetic Energy Correction Factor for a Converging–Diverging Nozzle
- 7 November 2021
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 86 (23) , 17213-17225
Asymmetric Synthesis of Bridged N-Heterocycles with Tertiary Carbon Center through Barbas Dienamine-Catalysis: Scope and Applications
A direct aza-Diels–Alder reaction between 2-aryl-3H-indolin-3-ones and cyclic-enones has been developed to access chiral indolin-3-one fused polycyclic bridged compounds. This method proceeds via proline-catalyzed Barbas-dienamine intermediate formation from various cyclic-enones such as 2-cyclopenten-1-one, 2-cyclohexene-1-one, and 2-cycloheptene-1-one, followed by a reaction with 2-aryl-3H-indol-3-ones. Several indolin-3-ones fusing [2.2.2], [2.2.1], and [3.2.1] skeletons decorated with a tertiary carbon chiral center have been prepared. Computational studies (DFT) supported the observed stereoselectivity in the method. The synthesized compounds have shown exciting photophysical activities and selective sensing of Pd2+ and Fe3+ ions through the fluorescence quenching “switch-off” mode.
- 7 November 2021
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 86 (23) , 17213-17225
Asymmetric Synthesis of Bridged N-Heterocycles with Tertiary Carbon Center through Barbas Dienamine-Catalysis: Scope and Applications
A direct aza-Diels–Alder reaction between 2-aryl-3H-indolin-3-ones and cyclic-enones has been developed to access chiral indolin-3-one fused polycyclic bridged compounds. This method proceeds via proline-catalyzed Barbas-dienamine intermediate formation from various cyclic-enones such as 2-cyclopenten-1-one, 2-cyclohexene-1-one, and 2-cycloheptene-1-one, followed by a reaction with 2-aryl-3H-indol-3-ones. Several indolin-3-ones fusing [2.2.2], [2.2.1], and [3.2.1] skeletons decorated with a tertiary carbon chiral center have been prepared. Computational studies (DFT) supported the observed stereoselectivity in the method. The synthesized compounds have shown exciting photophysical activities and selective sensing of Pd2+ and Fe3+ ions through the fluorescence quenching “switch-off” mode.
- 22 September 2021
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (23) , 12800-12811
In silico and in vitro assays reveal potential inhibitors against 3CLpro main protease of SARS-CoV-2
The COVID-19 pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is not showing any sign of slowing down even after the ongoing efforts of vaccination. The threats of new strains are concerning, as some of them are more infectious than the original one. A therapeutic against the disease is, therefore, of urgent need. Here, we use the DrugBank database to screen for potential inhibitors against the 3CLpro main protease of SARS-CoV-2. Instead of using the traditional approach of computational screening by docking, we developed a kernel ridge regressor (using a part of the docking data) to predict the binding energy of ligands. We used this model to screen the DrugBank database and shortlist two lead candidates (bromocriptine and avoralstat) for in vitro enzymatic study. Our results show that the 3CLpro enzyme activity in presence of 100 μM concentration of bromocriptine and avoralstat is 9.9% and 15.9%, respectively. Remarkably, bromocriptine exhibited submicromolar IC50 of 130 nM (0.13 μM). Avoralstat showed an IC50 of 2.16 μM. Further, the interactions of both drugs with 3CLpro were analyzed using molecular dynamics simulations of 100 ns. Results indicate that both ligands are stable in the binding pocket of the 3CLpro receptor. In addition, the MM-PBSA analysis revealed that bromocriptine (-29.37 kcal/mol) has a lower binding free energy compared to avoralstat (-6.91 kcal/mol). Further, hydrogen bond analysis also showed that bromocriptine interacts with the two catalytic residues, His41 and Cys145, more frequently than avoralstat. Communicated by Ramaswamy H. Sarma
- 22 September 2021
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (23) , 12800-12811
In silico and in vitro assays reveal potential inhibitors against 3CLpro main protease of SARS-CoV-2
The COVID-19 pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is not showing any sign of slowing down even after the ongoing efforts of vaccination. The threats of new strains are concerning, as some of them are more infectious than the original one. A therapeutic against the disease is, therefore, of urgent need. Here, we use the DrugBank database to screen for potential inhibitors against the 3CLpro main protease of SARS-CoV-2. Instead of using the traditional approach of computational screening by docking, we developed a kernel ridge regressor (using a part of the docking data) to predict the binding energy of ligands. We used this model to screen the DrugBank database and shortlist two lead candidates (bromocriptine and avoralstat) for in vitro enzymatic study. Our results show that the 3CLpro enzyme activity in presence of 100 μM concentration of bromocriptine and avoralstat is 9.9% and 15.9%, respectively. Remarkably, bromocriptine exhibited submicromolar IC50 of 130 nM (0.13 μM). Avoralstat showed an IC50 of 2.16 μM. Further, the interactions of both drugs with 3CLpro were analyzed using molecular dynamics simulations of 100 ns. Results indicate that both ligands are stable in the binding pocket of the 3CLpro receptor. In addition, the MM-PBSA analysis revealed that bromocriptine (-29.37 kcal/mol) has a lower binding free energy compared to avoralstat (-6.91 kcal/mol). Further, hydrogen bond analysis also showed that bromocriptine interacts with the two catalytic residues, His41 and Cys145, more frequently than avoralstat. Communicated by Ramaswamy H. Sarma